Follow
Pawel Wlodarski
Pawel Wlodarski
Dept of Methodology, Medical University of Warsaw
Verified email at wum.edu.pl
Title
Cited by
Cited by
Year
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway
T Skorski, A Bellacosa, M Nieborowska‐Skorska, M Majewski, R Martinez, ...
The EMBO journal, 1997
8161997
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity
M Marzec, M Kasprzycka, R Lai, AB Gladden, P Wlodarski, E Tomczak, ...
Blood 108 (5), 1744-1750, 2006
1702006
Possible mechanisms of disease development in tuberous sclerosis
J Jozwiak, S Jozwiak, P Wlodarski
The lancet oncology 9 (1), 73-79, 2008
1602008
Type II phosphatidylinositol 4-kinase β is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP
YJ Wei, HQ Sun, M Yamamoto, P Wlodarski, K Kunii, M Martinez, ...
Journal of Biological Chemistry 277 (48), 46586-46593, 2002
1462002
BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac
T Skorski, P Wlodarski, L Daheron, P Salomoni, M Nieborowska-Skorska, ...
Proceedings of the National Academy of Sciences 95 (20), 11858-11862, 1998
1421998
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway
M Marzec, M Kasprzycka, X Liu, M El-Salem, K Halasa, PN Raghunath, ...
Oncogene 26 (38), 5606-5614, 2007
1302007
Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase
T Skorski, M Nieborowska-Skorska, P Wlodarski, D Perrotti, R Martinez, ...
Proceedings of the National Academy of Sciences 93 (23), 13137-13142, 1996
1141996
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing
T Skorski, M Nieborowska-Skorska, P Wlodarski, M Wasik, R Trotta, ...
Blood, The Journal of the American Society of Hematology 91 (2), 406-418, 1998
1091998
Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf
M Marzec, M Kasprzycka, X Liu, PN Raghunath, P Wlodarski, MA Wasik
Oncogene 26 (6), 813-821, 2007
1072007
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3
M Marzec, M Kasprzycka, A Ptasznik, P Wlodarski, Q Zhang, N Odum, ...
Laboratory investigation 85 (12), 1544-1554, 2005
1052005
Palmitoylation controls the catalytic activity and subcellular distribution of phosphatidylinositol 4-kinase IIα
B Barylko, YS Mao, P Wlodarski, G Jung, DD Binns, HQ Sun, HL Yin, ...
Journal of biological chemistry 284 (15), 9994-10003, 2009
902009
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice
T Skorski, M Nieborowska-Skorska, P Wlodarski, G Zon, RV Iozzo, ...
891996
Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal …
P Wlodarski, M Kasprzycka, X Liu, M Marzec, ES Robertson, A Slupianek, ...
Cancer research 65 (17), 7800-7808, 2005
882005
The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation.
PR Franaszczyk M, Bilinska ZT, Sobieszczańska-Małek M, Michalak E, Sleszycka ...
J Transl Med. 12, 192, 2014
76*2014
Role of p53 in hematopoietic recovery after cytotoxic treatment
P Wlodarski, M Wasik, MZ Ratajczak, C Sevignani, G Hoser, J Kawiak, ...
Blood, The Journal of the American Society of Hematology 91 (8), 2998-3006, 1998
721998
Treatment of Philadelphia 1 Leukemia in Severe Combined Immunodeficient Mice by Combination of Cyclophosphamide and bcr/abl Antisense …
T Skorski, M Nieborowska-Skorska, P Wlodarski, D Perrotti, M Majewski, ...
Journal of the National Cancer Institute 89 (2), 124-133, 1997
711997
Pathogenesis of medulloblastoma and current treatment outlook
J Jozwiak, W Grajkowska, P Wlodarski
Medicinal Research Reviews 27 (6), 869-890, 2007
492007
Molecular determinants of activation and membrane targeting of phosphoinositol 4-kinase IIβ
G Jung, J Wang, P Wlodarski, B Barylko, DD Binns, H Shu, HL Yin, ...
Biochemical Journal 409 (2), 501-509, 2008
482008
Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders
M El-Salem, PN Raghunath, M Marzec, P Wlodarski, D Tsai, E Hsi, ...
Laboratory Investigation 87 (1), 29-39, 2007
472007
Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
C Sevignani, P Wlodarski, J Kirillova, WE Mercer, KG Danielson, RV Iozzo, ...
The Journal of clinical investigation 101 (8), 1572-1580, 1998
461998
The system can't perform the operation now. Try again later.
Articles 1–20